Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stroke: the way things really are

P Scheinberg1

  • 1Department of Neurology, University of Miami School of Medicine, Mount Sinai Hospital, Miami Beach, FL 33140.

Stroke
|June 1, 1994
PubMed
Summary

Distinguishing scientifically proven stroke prevention and management from anecdotal claims is crucial. Evidence-based therapies, supported by controlled trials, define the standard of care, not physician usage alone.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RECENT ADVANCES IN PHYSIOLOGICAL STUDIES ON CEREBROVASCULAR DISEASES.

A listing of research in the cardiovascular field·2014
Same author

Thymus transplantation restores the repertoires of forkhead box protein 3 (FoxP3)+ and FoxP3- T cells in complete DiGeorge anomaly.

Clinical and experimental immunology·2013
Same author

Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura.

Journal of thrombosis and haemostasis : JTH·2012
Same author

Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia.

Leukemia·2011
Same author

Relation between arterial pressure and blood flow in the foot.

The American journal of medicine·2010
Same author

Regulatory T-cell depletion does not prevent emergence of new CD25+ FOXP3+ lymphocytes after antigen stimulation in culture.

Cytotherapy·2008

Area of Science:

  • Neurology
  • Evidence-Based Medicine
  • Clinical Trials

Background:

  • Governmental regulations necessitate distinguishing scientifically validated therapeutic modalities from anecdotal information for stroke prevention and management.
  • Medico-legal considerations require a clear demarcation between proven and unproven stroke treatments.

Purpose of the Study:

  • To review evidence for established stroke prevention modalities in high-risk patients.
  • To discuss controversial or unproven therapies lacking scientific validation.
  • To emphasize the importance of evidence-based medicine in defining the standard of care for stroke.

Main Methods:

  • Systematic review of controlled clinical trials and scientific literature.
  • Analysis of evidence supporting antiplatelet drugs, anticoagulants, and endarterectomy for stroke prevention.
  • Discussion of therapeutic modalities lacking scientific proof.

Main Results:

  • Evidence for antiplatelet drugs, anticoagulants, and endarterectomy in stroke prevention is summarized, along with their limitations.
  • Therapeutic modalities without scientific proof, such as anticoagulation for progressing stroke, are critically examined.
  • Current treatments for acute stroke remain disappointing despite promising preclinical findings, possibly due to narrow therapeutic windows.

Conclusions:

  • Controlled, randomized, multiple-center clinical trials are effective in determining the efficacy of stroke therapies.
  • Anecdotal data in stroke treatment can be misleading and potentially harmful.
  • Awareness of established scientific knowledge versus unknowns is essential in stroke care.

Related Experiment Videos